##gff-version 3
##sequence-region P02647 1 267
P02647	UniProtKB	Signal peptide	1	18	.	.	.	Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:6328445,ECO:0000269|PubMed:6409108;Dbxref=PMID:6328445,PMID:6409108	
P02647	UniProtKB	Chain	19	267	.	.	.	ID=PRO_0000425323;Note=Proapolipoprotein A-I	
P02647	UniProtKB	Chain	25	267	.	.	.	ID=PRO_0000001939;Note=Apolipoprotein A-I	
P02647	UniProtKB	Chain	25	266	.	.	.	ID=PRO_0000001940;Note=Truncated apolipoprotein A-I	
P02647	UniProtKB	Repeat	68	89	.	.	.	Note=1	
P02647	UniProtKB	Repeat	90	111	.	.	.	Note=2	
P02647	UniProtKB	Repeat	112	122	.	.	.	Note=3%3B half-length	
P02647	UniProtKB	Repeat	123	144	.	.	.	Note=4	
P02647	UniProtKB	Repeat	145	166	.	.	.	Note=5	
P02647	UniProtKB	Repeat	167	188	.	.	.	Note=6	
P02647	UniProtKB	Repeat	189	210	.	.	.	Note=7	
P02647	UniProtKB	Repeat	211	232	.	.	.	Note=8	
P02647	UniProtKB	Repeat	233	243	.	.	.	Note=9%3B half-length	
P02647	UniProtKB	Repeat	244	267	.	.	.	Note=10	
P02647	UniProtKB	Region	68	267	.	.	.	Note=10 X approximate tandem repeats	
P02647	UniProtKB	Modified residue	110	110	.	.	.	Note=Methionine sulfoxide;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12576517;Dbxref=PMID:12576517	
P02647	UniProtKB	Modified residue	136	136	.	.	.	Note=Methionine sulfoxide;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12576517;Dbxref=PMID:12576517	
P02647	UniProtKB	Glycosylation	263	263	.	.	.	Note=N-linked (Glc) (glycation) lysine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8261628;Dbxref=PMID:8261628	
P02647	UniProtKB	Natural variant	27	27	.	.	.	ID=VAR_000605;Note=In Munster-3C. P->H;Dbxref=dbSNP:rs121912720	
P02647	UniProtKB	Natural variant	27	27	.	.	.	ID=VAR_000606;Note=P->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2512329;Dbxref=dbSNP:rs121912720,PMID:2512329	
P02647	UniProtKB	Natural variant	28	28	.	.	.	ID=VAR_000607;Note=In Munster-3B. P->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2512329;Dbxref=dbSNP:rs121912721,PMID:2512329	
P02647	UniProtKB	Natural variant	34	34	.	.	.	ID=VAR_000608;Note=In Baltimore. R->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2108924;Dbxref=dbSNP:rs28929476,PMID:2108924	
P02647	UniProtKB	Natural variant	50	50	.	.	.	ID=VAR_000609;Note=In AMYL8%3B also found in a family with amyloid polyneuropathy-nephropathy Iowa. G->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:2123470,ECO:0000269|PubMed:3142462,ECO:0000269|PubMed:8208902;Dbxref=dbSNP:rs28931574,PMID:2123470,PMID:3142462,PMID:8208902	
P02647	UniProtKB	Natural variant	61	61	.	.	.	ID=VAR_025445;Note=A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15108119;Dbxref=dbSNP:rs12718465,PMID:15108119	
P02647	UniProtKB	Natural variant	84	84	.	.	.	ID=VAR_000610;Note=In AMYL8. L->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1502149;Dbxref=dbSNP:rs121912724,PMID:1502149	
P02647	UniProtKB	Natural variant	92	92	.	.	.	ID=VAR_017017;Note=Polymorphism%3B confirmed at protein level. T->I;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12966036,ECO:0000269|PubMed:22028381;Dbxref=dbSNP:rs766422306,PMID:12966036,PMID:22028381	
P02647	UniProtKB	Natural variant	113	113	.	.	.	ID=VAR_000611;Note=D->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2111322;Dbxref=dbSNP:rs150243849,PMID:2111322	
P02647	UniProtKB	Natural variant	119	119	.	.	.	ID=VAR_000612;Note=In Hita. A->D	
P02647	UniProtKB	Natural variant	126	126	.	.	.	ID=VAR_016189;Note=D->H;Dbxref=dbSNP:rs5077	
P02647	UniProtKB	Natural variant	127	127	.	.	.	ID=VAR_000613;Note=In Munster-3A. D->N;Dbxref=dbSNP:rs921646982	
P02647	UniProtKB	Natural variant	131	131	.	.	.	ID=VAR_000615;Note=K->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2111322;Dbxref=dbSNP:rs4882,PMID:2111322	
P02647	UniProtKB	Natural variant	131	131	.	.	.	ID=VAR_000614;Note=In Marburg/Munster-2. Missing	
P02647	UniProtKB	Natural variant	132	132	.	.	.	ID=VAR_000616;Note=In Tsushima. W->R	
P02647	UniProtKB	Natural variant	134	134	.	.	.	ID=VAR_000617;Note=In Fukuoka. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2107878;Dbxref=PMID:2107878	
P02647	UniProtKB	Natural variant	160	160	.	.	.	ID=VAR_000618;Note=In Norway. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:6432779;Dbxref=dbSNP:rs121912718,PMID:6432779	
P02647	UniProtKB	Natural variant	163	163	.	.	.	ID=VAR_000619;Note=E->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2111322;Dbxref=dbSNP:rs758509542,PMID:2111322	
P02647	UniProtKB	Natural variant	167	167	.	.	.	ID=VAR_000620;Note=In Giessen. P->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:6489332;Dbxref=dbSNP:rs121912719,PMID:6489332	
P02647	UniProtKB	Natural variant	168	168	.	.	.	ID=VAR_000621;Note=In Zaragoza. L->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.57	
P02647	UniProtKB	Natural variant	171	171	.	.	.	ID=VAR_000622;Note=E->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2111322;Dbxref=dbSNP:rs1015066427,PMID:2111322	
P02647	UniProtKB	Natural variant	173	173	.	.	.	ID=VAR_074073;Note=In Boston%3B no evidence of association with premature coronary heart disease%3B associated with decreased levels of HDL cholesterol%3B associated with decreased serum cellular cholesterol efflux%3B associated with decreased lecithin-cholesterol acyltransferase (LCAT) activity. R->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26073399;Dbxref=PMID:26073399	
P02647	UniProtKB	Natural variant	180	180	.	.	.	ID=VAR_021362;Note=In Oita%3B 60%25 of normal apoA-I and normal HDL cholesterol levels%3B rapidly cleared from plasma. V->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9514407;Dbxref=dbSNP:rs121912727,PMID:9514407	
P02647	UniProtKB	Natural variant	184	184	.	.	.	ID=VAR_014609;Note=R->P;Dbxref=dbSNP:rs5078	
P02647	UniProtKB	Natural variant	189	189	.	.	.	ID=VAR_000623;Note=P->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2512329;Dbxref=dbSNP:rs121912722,PMID:2512329	
P02647	UniProtKB	Natural variant	197	197	.	.	.	ID=VAR_000624;Note=In Milano%3B no evidence of association with premature vascular disease%3B associated with decreased HDL levels and moderate increase in triglycerides%3B allows the formation of disulfide-linked homodimers via the introduced cysteine%3B assembles properly in HDL%3B alters protein structure%3B has no tendency to form fibrils and aggregates. R->C;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:24755625,ECO:0000269|PubMed:6401735;Dbxref=dbSNP:rs28931573,PMID:24755625,PMID:6401735	
P02647	UniProtKB	Natural variant	222	222	.	.	.	ID=VAR_000625;Note=In Munster-4. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2111322;Dbxref=dbSNP:rs121912717,PMID:2111322	
P02647	UniProtKB	Sequence conflict	32	32	.	.	.	Note=W->P;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P02647	UniProtKB	Helix	33	42	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3R2P	
P02647	UniProtKB	Helix	45	59	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3R2P	
P02647	UniProtKB	Helix	61	65	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3R2P	
P02647	UniProtKB	Helix	80	88	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3R2P	
P02647	UniProtKB	Helix	93	158	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3R2P	
P02647	UniProtKB	Turn	159	164	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3R2P	
P02647	UniProtKB	Helix	166	203	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3R2P	
P02647	UniProtKB	Turn	229	232	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2MSC	
P02647	UniProtKB	Helix	233	260	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2MSC	
